Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy
Thomas A. Waldmann, Jing Chen
Annual Review of Immunology (2017) Vol. 35, Iss. 1, pp. 533-550
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Daniella M. Schwartz, Yuka Kanno, Alejandro V. Villarino, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 843-862
Open Access | Times Cited: 1021
Cytokines in Cancer Immunotherapy
Thomas A. Waldmann
Cold Spring Harbor Perspectives in Biology (2017) Vol. 10, Iss. 12, pp. a028472-a028472
Open Access | Times Cited: 419
Cytokines in the Treatment of Cancer
Kevin C. Conlon, Miloš D. Miljković, Thomas A. Waldmann
Journal of Interferon & Cytokine Research (2018) Vol. 39, Iss. 1, pp. 6-21
Open Access | Times Cited: 412
Erratum: JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Daniella M. Schwartz, Yuka Kanno, Alejandro V. Villarino, et al.
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 1, pp. 78-78
Open Access | Times Cited: 315
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
Jinfang Zhang, Fabin Dang, Junming Ren, et al.
Trends in Biochemical Sciences (2018) Vol. 43, Iss. 12, pp. 1014-1032
Open Access | Times Cited: 182
<p>JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data</p>
Robert Harrington, Shamma Ahmad Al Nokhatha, Richard Conway
Journal of Inflammation Research (2020) Vol. Volume 13, pp. 519-531
Open Access | Times Cited: 168
Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development
Abdolmajid Ghasemian, Hadeel A. Omear, Yaser Mansoori, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 44
Fine-Tuning Cytokine Signals
Jian‐Xin Lin, Warren J. Leonard
Annual Review of Immunology (2019) Vol. 37, Iss. 1, pp. 295-324
Open Access | Times Cited: 125
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
Camille Laurent, Alina Nicolae, Cécile Laurent, et al.
Blood (2019)
Open Access | Times Cited: 111
Peripheral T cell lymphomas: from the bench to the clinic
Danilo Fiore, Luca Vincenzo Cappelli, Alessandro Broccoli, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 6, pp. 323-342
Closed Access | Times Cited: 105
Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
Volker Schirrmacher, Stefaan Van Gool, Wilfried Stuecker
Biomedicines (2019) Vol. 7, Iss. 3, pp. 66-66
Open Access | Times Cited: 87
Basic Mechanisms of JAK Inhibition
Chung Mun Alice Lin, Faye A. H. Cooles, John D. Isaacs
Mediterranean Journal of Rheumatology (2020) Vol. 31, Iss. Suppl 1, pp. 100-100
Open Access | Times Cited: 87
Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
Li Lü, Fen Zhu, Meili Zhang, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 3
Open Access | Times Cited: 84
Direct Targeting Options for STAT3 and STAT5 in Cancer
Anna Orlova, Christina Wagner, Elvin D. de Araujo, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1930-1930
Open Access | Times Cited: 82
The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity
Jiajia Zhou, Ilona Kryczek, Shasha Li, et al.
Nature Immunology (2021) Vol. 22, Iss. 4, pp. 460-470
Open Access | Times Cited: 76
ACVIMconsensus statement guidelines on diagnosing and distinguishing low‐grade neoplastic from inflammatory lymphocytic chronic enteropathies in cats
Sina Marsilio, Valérie Freiche, Eric Johnson, et al.
Journal of Veterinary Internal Medicine (2023) Vol. 37, Iss. 3, pp. 794-816
Open Access | Times Cited: 37
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
STAT3 Activation and Oncogenesis in Lymphoma
Fen Zhu, Kevin Boyang Wang, Lixin Rui
Cancers (2019) Vol. 12, Iss. 1, pp. 19-19
Open Access | Times Cited: 68
Structural and functional consequences of the STAT5BN642H driver mutation
Elvin D. de Araujo, Fettah Erdogan, Heidi A. Neubauer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 67
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
Marie Brachet‐Botineau, Marion Polomski, Heidi A. Neubauer, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 240-240
Open Access | Times Cited: 65
Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus
Florah Moshapa, Kirsten Riches‐Suman, Timothy M. Palmer
Cardiology Research and Practice (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 61
STAT5A and STAT5B—Twins with Different Personalities in Hematopoiesis and Leukemia
Barbara Maurer, Sebastian Kollmann, Judith Pickem, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1726-1726
Open Access | Times Cited: 60
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma
Audrey Letourneau, Marie Maerevoet, Dina Milowich, et al.
Virchows Archiv (2018) Vol. 473, Iss. 4, pp. 505-511
Open Access | Times Cited: 59
<p>Cannabidiol as a Novel Therapeutic for Immune Modulation</p>
Nadia Peyravian, Sapna K. Deo, Sylvia Daunert, et al.
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 131-140
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top